Ben Tre Pharmaceutical JSC (HOSE: DBT)

DBT Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	30,387	33,102	45,956	68,167	40,535	43,598
Short-Term Investments	52,768	49,000	37,181	37,417	21,011	-
Cash & Short-Term Investments	83,156	82,102	83,136	105,584	61,546	43,598
Cash Growth	3.97%	-1.24%	-21.26%	71.55%	41.17%	103.55%
Accounts Receivable	134,831	132,844	153,568	144,752	129,534	92,077
Other Receivables	19,213	12,189	21,875	9,373	8,904	9,917
Receivables	154,045	145,033	175,444	154,125	138,438	101,994
Inventory	327,896	279,794	174,022	180,418	178,938	177,674
Prepaid Expenses	1,502	631.51	1,402	673.31	1,024	111.4
Other Current Assets	14,451	17,255	9,919	8,693	4,349	74,795
Total Current Assets	581,049	524,815	443,922	449,493	384,294	398,172
Property, Plant & Equipment	74,436	81,384	85,170	88,287	59,932	22,773
Long-Term Investments	56,393	50,978	54,467	58,226	73,664	10,780
Goodwill	4,998	4,844	6,137	6,896	3,202	-
Other Intangible Assets	3,881	4,002	4,306	5,563	5,991	4,671
Long-Term Deferred Tax Assets	637.85	-	1,187	1,048	-	-
Other Long-Term Assets	23,608	33,792	22,206	7,529	4,770	3,703
Total Assets	745,003	699,815	617,395	617,043	531,854	440,101
Accounts Payable	102,451	124,933	130,527	129,649	148,495	108,978
Accrued Expenses	11,934	3,852	9,271	13,985	12,941	19,563
Short-Term Debt	369,308	314,867	221,180	219,923	197,081	191,351
Current Portion of Long-Term Debt	-	-	-	-	-	270
Current Portion of Leases	-	-	-	-	-	193.11
Current Income Taxes Payable	2,126	4,407	4,750	1,255	2,392	4,081
Current Unearned Revenue	180	180	163.64	163.64	163.64	-
Other Current Liabilities	1,771	1,953	11,327	1,645	11,345	1,669
Total Current Liabilities	487,770	450,191	377,218	366,620	372,418	326,107
Long-Term Debt	11,502	11,461	-	-	-	110.83
Long-Term Deferred Tax Liabilities	756.11	597.52	280.34	-	-	-
Other Long-Term Liabilities	180.5	130.5	93	99	171.17	43
Total Liabilities	500,208	462,380	377,592	366,719	372,590	326,261
Common Stock	135,288	135,288	123,145	123,145	76,998	76,998
Additional Paid-In Capital	433.06	433.06	538.06	538.06	538.06	538.06
Retained Earnings	49,926	42,986	43,273	53,995	48,551	29,850
Comprensive Income & Other	2,587	2,587	2,587	2,587	2,587	6,454
Total Common Equity	188,234	181,294	169,542	180,265	128,674	113,840
Minority Interest	56,561	56,141	70,261	70,058	30,590	-
Shareholders' Equity	244,795	237,435	239,804	250,323	159,264	113,840
Total Liabilities & Equity	745,003	699,815	617,395	617,043	531,854	440,101
Total Debt	380,810	326,328	221,180	219,923	197,081	191,925
Net Cash (Debt)	-297,654	-244,226	-138,044	-114,339	-135,536	-148,327
Net Cash Per Share	-16709.57	-	-	-7104.37	-10988.82	-13319.38
Filing Date Shares Outstanding	17.81	-	-	16.09	12.33	11.66
Total Common Shares Outstanding	17.81	-	-	16.09	12.33	11.66
Working Capital	93,279	74,624	66,704	82,873	11,875	72,065
Book Value Per Share	10566.98	-	-	11200.66	10432.49	9764.07
Tangible Book Value	179,356	172,448	159,100	167,806	119,480	109,169
Tangible Book Value Per Share	10068.58	-	-	10426.54	9687.10	9363.42
Buildings	-	-	-	-	-	28,495
Machinery	-	-	-	-	-	9,469
Construction In Progress	1,136	2,000	-	-	109.09	66.36

Source: S&P Capital IQ. Standard template. Financial Sources.